DocCheck AG (HAM:AJ91) ROCE %: 20.47% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HAM:AJ91 DocCheck AG HAM:AJ91
71 GF Score
Price €11.90
GF Value €9.52
! 3 Warning Signs
View Full Analysis

What is DocCheck AG ROCE %?

DocCheck AG HAM:AJ91 +0.85% 71 ROCE % is 20.47% as of Dec. 2025. GuruFocus rates HAM:AJ91 with a GF Score™ of 71/100 and a GF Value™ of €9.52. The stock has 3 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. DocCheck AG's annualized ROCE % for the quarter that ended in Dec. 2025 was 20.47%.

DocCheck AG  (HAM:AJ91) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

DocCheck AG ROCE % Related Terms

DocCheck AG ROCE % Historical Data

* Premium members only.

The historical data trend for DocCheck AG's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DocCheck AG ROCE % Chart

DocCheck AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 45.29 23.24 10.12 17.71 19.60

DocCheck AG Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.30 13.58 22.43 19.53 20.47
HAM:AJ91
71GF Score
DocCheck AG HAM:AJ91
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DocCheck AG ROCE % Calculation

DocCheck AG's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=8.755/( ( (58.125 - 13.792) + (55.675 - 10.659) )/ 2 )
=8.755/( (44.333+45.016)/ 2 )
=8.755/44.6745
=19.60 %

DocCheck AG's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=8.996/( ( (53.979 - 11.12) + (55.675 - 10.659) )/ 2 )
=8.996/( ( 42.859 + 45.016 )/ 2 )
=8.996/43.9375
=20.47 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 20.47% mean?
DocCheck AG (HAM:AJ91) has a ROCE % of 20.47% as of Dec. 2025.
Is DocCheck AG's ROCE % too high?
DocCheck AG's current ROCE % is 20.47%. The Healthcare Providers & Services industry median ROCE % is 6.34. DocCheck AG's value of 20.47% is 222.9% above this industry median. Overall, DocCheck AG has a GF Score™ of 71/100, reflecting its overall financial health beyond just this single metric.
How does DocCheck AG's ROCE % compare to VEEV and BTSG?
DocCheck AG's ROCE % of 20.47% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.34. DocCheck AG's value of 20.47% is 222.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.34, based on 642 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DocCheck AG's current ROCE % of 20.47% is 222.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DocCheck AG's current ROCE % is 20.47%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DocCheck AG stock overvalued right now?
DocCheck AG (HAM:AJ91) has a current ROCE % of 20.47%. The stock's GF Value™ is €9.52, compared to a current price of €11.90 — trading 25% above its estimated fair value. The current ROCE % is 20.47% and 222.9% above the Healthcare Providers & Services industry median of 6.34. DocCheck AG's overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For DocCheck AG (HAM:AJ91), the current ROCE % is 20.47% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DocCheck AG (HAM:AJ91) Overvalued in 2026?

Based on GuruFocus' analysis, DocCheck AG stock appears to be overvalued. The current stock price of €11.90 is trading 25% above its estimated GF Value™ of €9.52.

Key valuation signals for HAM:AJ91:

  • ROCE %: 20.47%
  • GF Value™: €9.52 vs. price of €11.90 (25% above fair value)
  • GF Score™: 71/100 with 3 warning signs
  • Industry Position: 222.9% above the Healthcare Providers & Services median

No single metric tells the full story. See the HAM:AJ91 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

DocCheck AG Business Description

Other Exchanges AJ91:Germany
Address Doccheck AG, Vogelsanger Strac E 66, Koln, DEU, 50823
DocCheck AG is a Germany-based company engaged in the healthcare sector. It operates through subsidiaries: antwerpes AG develops integrated communication concepts for the healthcare sector, including social media and digital communication with focus on e-marketing concepts, search engine optimization (SEO), search engine advertising (SEA) and search engine marketing (SEM); DocCheck Medical Services GmbH operates an online platform for healthcare professionals, such as physicians and pharmacists; DocCheck Medizinbedarf und Logistik GmbH wholesales medical products from third parties and also produces own medical products, and DocCheck Guano AG is a venture capital company with focus on e-health companies and promotes healthcare startups.
71GF Score

Get the complete analysis for HAM:AJ91

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€11.90
Price
€9.52
GF Value